Blasini, A M <br/><br/>
T lymphocytes from patients with systemic lupus erythematosus show increased response to interleukin-2 after costimulation with OKT3 monoclonal antibody and phorbol esters.  [electronic resource] 

 -  Clinical immunology and immunopathology  Jan 1994 
 - 66-72 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0090-1229 
<br/><br/><label>Standard No.: </label>10.1006/clin.1994.1012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Humans<br/>Interleukin-2--metabolism<br/>Lupus Erythematosus, Systemic--immunology<br/>Lymphocyte Activation<br/>Middle Aged<br/>Muromonab-CD3--immunology<br/>Receptors, Interleukin-2--analysis<br/>T-Lymphocytes--drug effects<br/>Tetradecanoylphorbol Acetate--pharmacology